Literature DB >> 7629366

Quality of care in cataract surgery cases experiencing post-operative complications with co-managed care.

D A Revicki1, M L Poe.   

Abstract

BACKGROUND: The quality of co-managed services and the ability of community optometrists to diagnose complications following cataract surgery were investigated in a previous study of 2,458 cases. Questions were raised about the quality of co-managed care in 50 of the cases; this study evaluates the care received by these patients.
METHODS: Medical records for 44 cases (6 cases could not located) were reviewed to determine whether community optometrists diagnosed post-surgical complications and whether cases were effectively managed. All reviews were performed by two optometrists and an ophthalmologist. Six cases were excluded because of no complication or attribution to underlying disease.
RESULTS: In 34 of the 38 remaining cases (89.5%), co-management was successful in diagnosing complications and in managing the patient to maximize vision function. 99.8% (2,454 of 2,458) of co-managed cases contained evidence that the optometrists provided high quality post-operative care and were able to diagnose complications. Using physician evaluations as the standard, the sensitivity of detection of complications by optometrists was 95.9% and the specificity was 99.5%.
CONCLUSIONS: Co-managing optometrists provide quality care and can diagnose post-operative complications.

Entities:  

Mesh:

Year:  1995        PMID: 7629366

Source DB:  PubMed          Journal:  J Am Optom Assoc        ISSN: 0003-0244


  2 in total

1.  Changing trends in postoperative cataract care: impact of electronic patient records in optometrist-delivered shared care.

Authors:  A M Mongan; F Kerins; B McKenna; S M Quinn; P Mullaney
Journal:  Ir J Med Sci       Date:  2017-10-23       Impact factor: 1.568

2.  Community optometrist-led post-operative cataract care: how many patients re-present to the hospital ophthalmic department?

Authors:  Amy O'Regan; Aisling McGlacken-Byrne; Shivona Chetty; Paul Mullaney
Journal:  Ir J Med Sci       Date:  2021-01-25       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.